Nifoxipam is a benzodiazepine analog utilized in scientific studies that explore central nervous system (CNS) modulation, GABAergic receptor binding, and psychoactive structure-activity relationships (SAR). Due to its unique fluorinated and nitro-substituted structure, it presents research interest in understanding the pharmacological differences between classical benzodiazepines and newer analogs. Its long-lasting properties and relatively low abuse potential make it a suitable candidate for in vitro, in vivo, and computational modeling applications.

• GABA-A receptor binding studies: Nifoxipam interacts with GABA-A receptors, enabling researchers to study binding affinity, receptor modulation, and downstream neural inhibition in a controlled environment.

• Structure-activity relationship analysis: Researchers often examine Nifoxipam’s molecular structure—particularly the fluorine and nitro substitutions—to understand how these modifications affect potency, half-life, and receptor specificity.

• Neuropharmacological profiling: It is used to assess sedative, anxiolytic, and hypnotic properties in rodent models to map behavioral responses and pharmacokinetics.

• Analytical chemistry testing: Nifoxipam is frequently utilized in chromatographic and spectroscopic calibration studies such as HPLC, GC-MS, or NMR-based quantification experiments.

• Comparative pharmacology: Due to its similarities and differences with compounds like Diazepam or Flunitrazepam, Nifoxipam helps delineate key pharmacodynamic distinctions in benzodiazepine research.

• Toxicological benchmarking: Toxicity studies in controlled conditions help evaluate safety margins, LD50 thresholds, and potential cellular impacts under laboratory parameters.

The legality of Nifoxipam varies by jurisdiction and often hinges on national drug scheduling systems and analogue legislation. While it remains unscheduled in many regions, buyers must be diligent about complying with local, regional, and institutional regulations before purchasing or importing this compound for research purposes.

• Unscheduled status in many countries: Nifoxipam is not classified as a controlled substance under the United Nations drug schedules, making it technically legal to possess for research in various regions.

• Subject to analogue laws: Some countries (e.g., the U.S. under the Federal Analogue Act) may interpret Nifoxipam as a controlled analogue if intended for human consumption, despite its structural differences.

• Institutional usage compliance: Universities and licensed research facilities must validate their legal authority to handle unscheduled compounds, especially during audits or customs inquiries.

• RC Plug’ policy: We require all customers to acknowledge legal responsibility before checkout and do not sell or ship to areas where Nifoxipam is explicitly banned.

• Import regulations: In some jurisdictions, customs may request documentation or a research justification letter. It’s advised to retain proof of research purpose and purity documentation when ordering internationally.

Nifoxipam’s observed effects in research settings closely mirror traditional benzodiazepines but with certain distinctive properties such as delayed onset and extended duration. Studies typically focus on its behavioral, cognitive, and sedative-hypnotic effects in animal models or cellular assays.

• CNS depressant activity: Nifoxipam demonstrates notable inhibitory effects on central nervous system activity, similar to other benzodiazepines, through GABA-A receptor modulation.

• Anxiolytic properties: In animal-based research, it exhibits dose-dependent anxiolytic-like responses that are measured using elevated plus maze or open field tests.

• Hypnotic and sedative action: It has been observed to induce sedation and sleep in rodent studies, making it suitable for investigating circadian rhythm interference or sleep onset latency.

• Delayed onset, long half-life: Compared to fast-acting compounds, Nifoxipam shows a slower onset but longer-lasting effects, which may inform studies focused on prolonged CNS modulation.

• Reduced abuse potential in models: While all psychoactive substances require handling precautions, Nifoxipam appears to have a lower rewarding profile than some high-potency benzodiazepines, based on conditioned place preference studies.

Nifoxipam exhibits moderate-to-high potency, placing it between Diazepam and Flunitrazepam in terms of strength and receptor affinity. Researchers often analyze its effects relative to structurally similar compounds to determine efficacy, onset, and therapeutic index under lab settings.

• More potent than Diazepam: Experimental data suggest that Nifoxipam exerts stronger GABA-A receptor modulation at lower doses compared to Diazepam, making it useful in dose-sensitivity studies.

• Less potent than Flunitrazepam: While highly active, it does not reach the potency or fast-acting characteristics of Flunitrazepam, which helps define a clearer pharmacological hierarchy in benzodiazepine research.

• Longer duration enhances utility: Its prolonged effect profile makes it more suitable for studies requiring continuous GABAergic activation or multi-hour behavioral tracking.

• Potency influenced by substitution: The presence of a fluorine atom and nitro group in its molecular structure contributes to its increased binding affinity, compared to unsubstituted analogs.

• Utility in threshold dose experiments: Because of its intermediate potency, Nifoxipam can be used to establish effective dose ranges and safety windows across various in vitro and in vivo test systems.

We provide Nifoxipam in two highly reliable formats—crystalline powder and compressed pellets—each tailored for different research needs. Every order is shipped with full batch documentation, including Certificates of Analysis (COAs) and purity verification.

• Crystalline powder format: Suitable for weighing with precision microbalances, this format supports solvent dissolution, spectroscopic testing, and chemical reactivity studies.

• Pellet format: Ideal for behavioral pharmacology or fixed-dose assays, our pellets are standardized in dose and mass for reproducibility in repeated trials.

• Vacuum-sealed packaging: Both formats are sealed in moisture-resistant, oxygen-limited packaging to maintain compound integrity during transport and storage.

• Batch-specific documentation: We include COAs detailing purity, synthesis batch, and test methodology to support your lab’s compliance and data accuracy.

• Flexible quantity options: We offer quantities starting at 100 mg or 1 pellet, scaling up to bulk orders for academic or institutional buyers.

• Stable for long-term use: Properly stored, both formats maintain potency and stability for up to 24 months from the manufacture date.

Nifoxipam sold by RC Plug is strictly intended for scientific research and not for human or veterinary consumption. Despite its classification as a benzodiazepine analog, it has not been approved by any health authority for medicinal use. Using it outside of laboratory conditions may pose legal, ethical, and health risks.

• Not approved for human consumption: Nifoxipam is not licensed for therapeutic use by the FDA, EMA, or any major drug authority, making any personal use strictly off-label and unlawful.

• Sold exclusively for research purposes: All our sales are governed by terms that prohibit recreational or therapeutic use. Any misuse voids our refund policy and violates purchase agreements.

• Potential health risks: The pharmacological profile of Nifoxipam is not fully established for safe dosing in humans. Misuse can lead to CNS depression, respiratory issues, or unexpected drug interactions.

• Legal implications: Possessing or using Nifoxipam for personal use in certain jurisdictions may breach analogue or controlled substance laws, potentially resulting in criminal charges.

• Ethical considerations: Using a research chemical for self-experimentation undermines the scientific process and endangers personal safety. We strongly discourage any application beyond authorized research protocols.

• RC Plug’ liability disclaimer: We assume no responsibility for use that violates intended research-only usage. Buyers must verify compliance with institutional and national guidelines.

To preserve the structural and chemical integrity of Nifoxipam, it is essential that it be stored under controlled environmental conditions. This helps maintain purity and stability over the product’s full shelf life, reducing the risk of degradation or contamination.

• Store in a cool environment: The optimal storage temperature is below 25°C (77°F). Prolonged exposure to high temperatures can degrade the compound’s molecular bonds.

• Avoid exposure to light: Nifoxipam should be kept in a dark or amber container to prevent photodegradation, especially for long-term storage.

• Keep dry and sealed: Use airtight, moisture-resistant containers to avoid hydrolysis and clumping of powder due to humidity.

• Refrigeration optional for long-term storage: For extended preservation (over 12 months), storing in a refrigerated setting (2–8°C) can further ensure compound stability, but is not mandatory if room conditions are well controlled.

• Use desiccants if available: Adding a silica gel packet inside storage containers helps maintain dryness in humid environments.

• Label and rotate inventory: Date and batch-code each container to track age and prioritize older samples first (FIFO: First-In, First-Out method).

We prioritize fast and discreet delivery to meet the time-sensitive needs of researchers. Shipping times vary by destination, but all orders are processed rapidly and include tracking to ensure visibility throughout the delivery process.

• Same-day processing available: Orders confirmed before our daily cut-off are typically dispatched the same business day.

• Overnight shipping for select countries: For destinations like the U.S., U.K., and parts of the EU, overnight or 1–2 day shipping is available via express couriers.

• Standard international delivery: For global destinations, orders typically arrive within 3 to 7 business days, depending on local customs and courier networks.

• Tracking number provided: Every order comes with a traceable shipping ID, allowing customers to monitor the delivery status in real-time.

• Stealth packaging ensures customs success: Our parcels are discreetly packed with no identifying labels or invoices that suggest chemical contents, minimizing customs delays or scrutiny.

• Priority processing for bulk orders: Larger orders from institutions and universities are processed with special handling and may receive shipping upgrades where applicable.

RC Plug has earned a solid reputation as a dependable, transparent, and professional supplier in the research chemical space. Our emphasis on quality control, secure logistics, and scientific support ensures we consistently meet the expectations of academic, pharmacological, and institutional clients.

• High-purity standards: Every compound, including Nifoxipam, is tested using HPLC, NMR, and MS techniques, with results documented in Certificates of Analysis (COAs).

• Secure and discreet fulfillment: Our global logistics network uses tamper-evident packaging, neutral labeling, and optimized customs routing to ensure seamless delivery.

• Diverse payment options: We support Bitcoin, bank transfers, Zelle, CashApp, and Western Union to provide maximum flexibility and privacy for research institutions and individuals alike.

• Customer-centric service: From order placement to delivery resolution, we offer responsive support, technical documentation, and personalized help when needed.

• Ethical compliance: We maintain strict policies against recreational or misuse-related purchases and require confirmation that all products will be used legally for research.

• 30-day refund or replacement guarantee: In cases of shipping loss, damage, or defective product, we ensure your research isn’t disrupted by offering a swift resolution.

• Institutional trust: Our client base includes researchers from universities, private labs, pharmacology teams, and analytical chemists—testament to our reliability and credibility in the field.

Understanding the physical properties of Nifoxipam is critical for accurate handling, identification, and formulation in laboratory settings. Its appearance may vary slightly depending on the batch and format (powder or pellet), but its fundamental characteristics remain consistent.

• Crystalline powder: Most commonly, Nifoxipam is supplied as a fine, white to off-white crystalline powder, easily measurable and mixable for solution-based or dry compound assays.

• Compressed pellet format: Pellets are uniform, small disc-shaped tablets, typically white or lightly colored for differentiation. They are made under controlled pressure without excipients unless stated.

• Non-hygroscopic in sealed form: Properly packaged, the compound does not readily absorb atmospheric moisture, which preserves its structural composition.

• Free of visible contaminants: Each batch undergoes visual inspection and meets ISO clean-room packaging standards to eliminate physical impurities or irregular textures.

• Batch-coded packaging: The container is labeled with a lot number and expiration date, supporting accurate record-keeping and inventory control.

Handling Nifoxipam in a laboratory setting requires adherence to chemical safety protocols to prevent contamination, exposure, or accidents. While it is not considered highly toxic in small quantities, it still poses potential hazards if mishandled, particularly due to its CNS-active properties. Proper lab procedures protect personnel, equipment, and data integrity.

• Use personal protective equipment (PPE): Always wear lab-grade gloves, protective eyewear, and a lab coat when handling Nifoxipam to avoid dermal or ocular exposure.

• Work under a fume hood: Nifoxipam should be manipulated in a well-ventilated area or fume hood to prevent inhalation of airborne particles, especially during weighing or powder dissolution.

• Avoid ingestion or skin contact: As a CNS-active agent, accidental ingestion or absorption may cause harmful effects. Any accidental exposure should be addressed immediately with medical consultation.

• Use precision instruments: Weighing and transferring should be done using calibrated microbalances and non-reactive tools (glass or plastic) to ensure accurate dosage and avoid chemical interactions.

• Label and isolate the workspace: Always label containers and designated workstations when handling research chemicals. Maintain a log of use and disposal in compliance with lab SOPs.

• Store separately: Nifoxipam should be stored away from acids, bases, or volatile reagents to prevent chemical incompatibility and degradation.

• Disposal must follow hazardous waste regulations: Any leftover material, spills, or containers should be disposed of according to your institution’s hazardous chemical waste disposal procedures.

Yes, we actively support large-scale research initiatives and institutional procurement by offering flexible pricing and volume discounts on Nifoxipam and other compounds. We encourage long-term partnerships and are committed to providing cost-effective solutions for high-volume buyers.

• Discounts on quantity tiers: Reduced rates are available for orders exceeding thresholds such as 10g, 25g, or 100g for powder, or 50+ pellets, depending on format and availability.

• Custom bulk quotations: Institutions and research teams can request tailored quotes, especially for recurring or large-scale projects.

• Priority fulfillment for large orders: Bulk purchases receive expedited processing and packaging preference, minimizing lead times for mission-critical research.

• Scheduled deliveries: For ongoing experiments, we can arrange monthly or quarterly shipments, ensuring supply consistency for longitudinal research programs.

• Loyalty pricing: Returning bulk clients may qualify for preferred pricing tiers or limited-time offers as part of our loyalty program.

• Institutional invoicing available: For universities, pharmaceutical teams, and private labs, we offer invoice-based payment structures upon approval.

Nifoxipam has a well-documented stability profile when stored under optimal conditions. Its shelf life primarily depends on how well the compound is protected from environmental degradation such as humidity, light, and high temperature.

• Typical shelf life is 24 months: When sealed and stored under ideal lab conditions (≤25°C, low humidity, dark storage), Nifoxipam retains full potency for at least 2 years from the manufacture date.

• Shelf life indicated on packaging: Each unit is labeled with the production and expiry date, allowing researchers to track usability windows accurately.

• Stability confirmed through periodic testing: Long-term retention samples are used to assess ongoing chemical stability under ICH guidelines.

• Refrigeration enhances longevity: While not required, storing at 2–8°C can prolong the lifespan and slow any potential oxidative degradation.

• Keep desiccated and sealed: Exposure to moisture or repeated opening of the container may shorten shelf life and affect purity.

• Degradation may not be visible: Even if the compound appears unchanged visually, loss of efficacy can occur, reinforcing the importance of using within the labeled time frame.

Our return and refund policy is designed to protect the integrity of research chemicals while offering a safety net for legitimate concerns. Due to the sensitive nature of chemical substances, returns are only accepted under specific, justified conditions to maintain product purity and regulatory compliance.

• Returns are allowed for unopened, sealed products: To qualify for a return, the Nifoxipam must be in its original, untampered vacuum-sealed packaging.

• 30-day replacement or refund window: If the product is defective, damaged, or not as described, clients can initiate a refund or replacement request within 30 days of receipt.

• Change-of-mind returns not accepted once shipped: For product safety reasons, we do not accept returns based on personal reconsideration after the product has left our facility.

• Shipping errors covered: If an incorrect item or quantity is shipped, we’ll replace it at no cost, including expedited shipping.

• Lost or undelivered packages qualify for reimbursement: If your tracking status shows loss or extended delay beyond 14 business days, we offer full compensation or a new shipment.

• Easy claims process: To initiate a return or refund, contact our support team with your order number, photos (if applicable), and reason for the request.

Yes, RC Plug ships to all major research hubs worldwide, including the United States, United Kingdom, European Union countries, Australia, and Canada, provided that local regulations permit the import of unscheduled research chemicals like Nifoxipam.

• United States: We ship Nifoxipam to the U.S. under research chemical provisions. Customers must verify it’s not banned in their state or subject to analogue restrictions.

• United Kingdom: Currently unscheduled in the U.K., making it accessible for academic and institutional research, provided it’s not intended for human consumption.

• European Union: Most EU nations accept delivery of unscheduled research chemicals for lab use. We include all necessary documentation for customs clearance.

• Australia: While Australia has strict customs policies, we have successful shipping records to verified institutions and recommend pre-clearance for private researchers.

• Canada: We’ve successfully fulfilled multiple shipments to Canadian labs. Clients are advised to confirm permissibility with Health Canada if required.

• Shipping documentation support: Upon request, we can provide pro forma invoices, purity statements, or research-use declarations to facilitate customs processing.

Verifying the purity of Nifoxipam is essential for ensuring accurate, reproducible results in research. RC Plug guarantees purity through lab validation, but we also empower clients with the documentation and tools needed to independently assess compound quality.

• Certificate of Analysis (COA) included: Every order of Nifoxipam ships with a COA containing analytical results such as purity percentage, batch number, and testing methods (HPLC, NMR, MS).

• Independent lab validation: Our products are tested in ISO-certified facilities using industry-standard techniques like high-performance liquid chromatography (HPLC) to confirm chemical identity and purity.

• Request raw data: Upon request, we can provide detailed chromatograms, spectra, or lab notes that support the reported purity values.

• Third-party retesting supported: You may submit a sample to an independent lab for cross-verification. Our documentation aligns with regulatory and quality assurance needs.

• Consistent batch labeling: Each container is marked with a lot number that corresponds to the COA, ensuring traceability for auditing or replication purposes.

• Minimal variance between batches: Our internal QC ensures purity deviations remain within ±1%, providing consistent results across studies.